Leveraging ICyte to Create a Competitive Edge in Generics Commercializatio

Success in commercializing generic drugs isn’t easy. The razor-thin profit margins require commercial leaders to have keen visibility into sales, demand, and inventory to ensure sufficient product availability and avoid stockout fees. Additionally, there is little room for revenue leakage, so being able to identify and eliminate excessive discounting or improper chargeback claims is a high priority. Recently, IntegriChain partnered with a large generics manufacturer with more than 100 NDCs across multiple therapeutic categories to migrate them from an inadequate, legacy system to the ICyte platform. Download below!